Characteristics, incidence, risk factors, and practical management of pneumonitis associated with anti-PD-1 immunotherapy in patients with non-small cell lung cancer
Conclusion: Anti-PD-1 antibodies should be used with caution when tumors are located proximal to the subsegmental branch. Anti-PD-1 antibodies can be used in patients with high CRP values. Attention to relapses must be paid when patients undergo invasive procedures.
Source: European Respiratory Journal - Category: Respiratory Medicine Authors: Moda, M. Tags: Lung cancer Source Type: research
More News: Cancer | Cancer & Oncology | Chemotherapy | CT Scan | Immunotherapy | Lung Cancer | Non-Small Cell Lung Cancer | PET Scan | Radiation Therapy | Respiratory Medicine